Global Plantar Fasciitis Treatment Market is expected to reach US$ XX Mn by 2026 from US$ XX Mn in 2019, at a CAGR of 7.2% during the forecast period.
Global Plantar Fasciitis Treatment Market Overview:
Plantar fasciitis is a type of repetitive strain injury that affects runners, hikers, and walkers, as well as practically everyone who works standing for a living, such as cashiers, especially on hard surfaces. Plantar fasciitis' multifactorial aetiology has resulted in a large increase in the number of sufferers, as well as a solid foundation for the creation of firms that treat the ailment.
Global Plantar Fasciitis Treatment Market Dynamics:
The rising prevalence of obesity is the main factor driving the market growth.
The global market is being driven by an increase in the use of orthotics, as well as an increase in the number of cases of plantar fasciitis. A wide range of treatments is emerging as a viable ally in the fight against severe heel pain caused by plantar fasciitis, broadening the possibility of growth for stakeholders.
Plantar fasciitis affects an estimated 2 million people worldwide each year, according to the National Centre for Health Statistics (NCHS). Furthermore, the expanding obesity population is contributing to the market's growth, as fat persons are more likely to acquire plantar fasciitis. Body mass index (BMI) was strongly associated with plantar fasciitis, according to a study published in The Journal of Pain by the National Centre for Complementary and Integrative Health (NCCIH).
Those with a BMI of 30 or more (1.48 %) were 5 times more likely to have plantar fasciitis than those with a BMI of less than 25. (0.29%). Though a sedentary, inactive lifestyle isn't the primary cause of plantar fasciitis, it does raise the likelihood of the condition. Furthermore, the shift in people's lifestyles toward sedentary activities, combined with their quickly changing eating habits, has resulted in a considerable increase in obesity cases.
Furthermore, the growing elderly population, technological developments, and the availability of various treatment choices are all driving the plantar fasciitis treatment market forward. The high cost of therapy and lack of understanding about the plantar fasciitis ailment, on the other hand, are impeding the plantar fasciitis treatment market's growth.
The report has profiled eighteen key players in the market from different regions. However, the report has considered all market leaders, followers and new entrants with investors while analyzing the market and estimation the size of the same. Increasing R&D activities in each region are different and focus is given on the regional impact on the cost, availability of advanced technology are analyzed and report has come up with recommendations for a future hot spot in APAC region.
Global Plantar Fasciitis Treatment Market Segment Analysis:
The Global Plantar Fasciitis Treatment Market is segmented on the basis of Treatment Type and End-Users.
Based on Treatment Type, the Orthotic Devices segment is expected to dominate during the forecast period. Orthotic devices, commonly known as orthoses, are braces that aid in the support of weakening muscles while jogging and walking. They also help to improve comfort and delay the progression of contractures (tightened muscles or tendons that become shorter over time). Wearing orthotic devices at any time of day or night is possible. The sort of orthotic device to be used depends on the patient's problem. Ankle-foot orthoses and knee-ankle-foot orthoses are the two most common types of orthotic devices. The prevalence of plantar fasciitis in United States adults was highest in women (1.19 %) compared to men (0.47 %), in population aged between 45 to 64 (1.33 %) versus population aged 18 to 44 (0.53 %).
Global Plantar Fasciitis Treatment Market
To know about the Research Methodology :- Request Free Sample Report
Global Plantar Fasciitis Treatment Market Regional Insights:
North America is expected to hold a dominant market share during the forecast period.
North America has a sizable market share in the global plantar fasciitis treatment market, which is projected to continue throughout the forecast period. Plantar fasciitis diagnosis and prevalence rates are steadily increasing in the region. Furthermore, the rise in the number of obese people in the United States, as well as changing lifestyles, are pushing the plantar fasciitis treatment market in the United States. According to the National Clinical Studies (NCT) registry, there are approximately 6 recruiting clinical trials in various stages of development for the treatment of Plantar Fasciitis in the United States as of June 18, 2020.
The report also helps in understanding the Global Plantar Fasciitis Treatment Market dynamics, structure by analyzing the market segments and project the Global Plantar Fasciitis Treatment Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Plantar Fasciitis Treatment Market make the report investor’s guide.
For More Information Visit @:
Global Plantar Fasciitis Treatment Market Scope:
Global Plantar Fasciitis Treatment Market, by Region
• North America
• Europe
• South America
• MEA
• APAC
Global Plantar Fasciitis Treatment Market Key Players
• Hanger, Inc.,
• Bayer Group (Dr. Scholl's),
• A. Algeo Limited,
• Bauerfeind AG,
• Superfeet Worldwide, Inc.,
• Ottobock SE & Co. KGaA (Ottobock Holding),
• Pfizer, Inc.,
• Sanofi, G
• GlaxoSmithKline plc.
• Recover Sports Medicine
• Shapecrunch Technology Pvt Ltd
• 3M
• UPMC
• OrthoBethesda
• APOTHECARY PRODUCTS, LLC
• Ellis & Badenhausen
• SYNXSOLE PTY LTD.
• Revance Therapeutics, Inc.
This Report Is Submitted By : Maximize Market Research Company
Customization of the report:
Maximize Market Research provides free personalized of reports as per your demand. This report can be personalized to meet your requirements. Get in touch with us and our sales team will guarantee provide you to get a report that suits your necessities.
About Maximize Market Research:
Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.
